A Study of Immune Responses to the Virus That Causes COVID-19
Public ClinicalTrials.gov record NCT04431414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn more about the acute response to infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this virus by the name "coronavirus." It can cause the disease called COVID-19. The information gained from the study can be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines, other prevention strategies, and treatments.
Study identification
- NCT ID
- NCT04431414
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 953 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 19, 2020
- Primary completion
- Jun 1, 2022
- Completion
- Jun 1, 2022
- Last update posted
- Jul 25, 2022
2020 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama CRS | Birmingham | Alabama | 35294 | — |
| Bridge HIV CRS | San Francisco | California | 94143 | — |
| University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS | Miami | Florida | 33136 | — |
| The Ponce de Leon Center CRS | Atlanta | Georgia | 30308 | — |
| The Hope Clinic of the Emory Vaccine Center CRS | Decatur | Georgia | 30030 | — |
| New Orleans Adolescent Trials Unit CRS | New Orleans | Louisiana | 70112 | — |
| Johns Hopkins University CRS | Baltimore | Maryland | 21205 | — |
| Brigham and Women's Hospital Vaccine CRS (BWH VCRS) | Boston | Massachusetts | 02115 | — |
| New Jersey Medical School Clinical Research Center CRS | Newark | New Jersey | 07103 | — |
| Columbia P&S CRS | New York | New York | 10032 | — |
| New York Blood Center CRS | New York | New York | 10065 | — |
| Chapel Hill CRS | Chapel Hill | North Carolina | 27599 | — |
| Case CRS | Cleveland | Ohio | 44106 | — |
| Penn Prevention CRS | Philadelphia | Pennsylvania | 19104 | — |
| Seattle Vaccine and Prevention CRS | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04431414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 25, 2022 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04431414 live on ClinicalTrials.gov.